Publications by authors named "Ana Carolina C Asbahr"

Cancer is a major public health problem in the world, being breast cancer the most frequent cancer affecting women. Despite advances in detection and treatment, mortality rates remain high. Therefore, new approaches for breast cancer treatments are necessary.

View Article and Find Full Text PDF

Melanoma is a severe metastatic skin cancer with poor prognosis and no effective treatment. Therefore, novel therapeutic approaches using nanotechnology have been proposed to improve therapeutic effectiveness. Lipid-core nanocapsules (LNCs), prepared with poly(ε-caprolactone), capric/caprylic triglyceride, and sorbitan monostearate and stabilized by polysorbate 80, are efficient as drug delivery systems.

View Article and Find Full Text PDF

The aim of this study was to determine whether inclusion complexes between 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) and finasteride (FIN) are formed, and to characterize these. Equimolar FIN/HPbetaCD solid systems in the presence or absence of 0.1% (w/v) of polyvinylpyrrolidone K30 (PVP K30) or 0.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ana Carolina C Asbahr"

  • Ana Carolina C Asbahr's research primarily focuses on the development of innovative drug delivery systems, particularly using lipid-core nanocapsules, to enhance treatment efficacy for various types of cancer, including breast cancer and melanoma.
  • Her studies demonstrate the potential of lipid-core nanocapsules to improve cytotoxicity and drug uptake in human cancer cell lines, suggesting a promising approach in combating resistant cancer types.
  • Additionally, Asbahr explores the formation and characterization of inclusion complexes involving finasteride and polymers, contributing to the understanding of drug formulation and potential applications in therapeutic settings.